Cleared Traditional

K894511 - MAGNETRON MUNICH MODEL ELECTRONIC CONTR...

K894511 is the FDA 510(k) clearance for MAGNETRON MUNICH MODEL ELECTRONIC CONTR... by Intl. Ophthalmic Industries Corp.. It is a Class 2 Ophthalmic device (product code HQC) cleared through the Traditional 510(k) pathway after a 90-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1989
Decision
90d
Days
Class 2
Risk

K894511 is an FDA 510(k) clearance for the MAGNETRON MUNICH MODEL ELECTRONIC CONTROL UNIT. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Intl. Ophthalmic Industries Corp. (Weston, US). The FDA issued a Cleared decision on October 17, 1989 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Intl. Ophthalmic Industries Corp. devices

Submission Details

510(k) Number K894511 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 1989
Decision Date October 17, 1989
Days to Decision 90 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 110d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 113
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K894511.
SITE 19 GAUGE ULTRASONIC I/A PHACO NEEDLE
K904151 · Site Microsurgical Systems, Inc. · Dec 1990
SITE PHACOEMULSIFICATION HANDPIECE
K904183 · Site Microsurgical Systems, Inc. · Dec 1990
NIDEK/PHACO EMULSIFICATION SYSTEM MODEL CV-8000
K901686 · Nidek, Inc. · Jun 1990
SITE PHACO PLUS INFUSION SLEEVE
K892852 · Site Microsurgical Systems, Inc. · Jun 1989
SITE PERISTALTIC CASSETTE
K892911 · Site Microsurgical Systems, Inc. · May 1989
CAVITRON/KELMAN PHACOEMULSIFIER ASPIRATOR, UNIV.
K890635 · CooperVision, Inc. · May 1989